Systems for cell culture scaling

US12227732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12227732-B2
Application numberUS-202218051126-A
CountryUS
Kind codeB2
Filing dateOct 31, 2022
Priority dateJan 17, 2018
Publication dateFeb 18, 2025
Grant dateFeb 18, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present set of embodiments relate to a bioproduction system, method, and apparatus for creating a scalable bioreactor system. Specifically, the present set of embodiments enable the determination of bioreaction performance characteristics of a commercial scale by matching operational parameters between a small test scale bioreaction to that of a commercial scale bioreaction. The system and methods do not rely on simply making bioreactor apparatuses across scales the same dimensionally which would not account for differences in fluid dynamic properties between very small to very large volumes, but requires tuning of a variety of systems (mixing assembly, sparger system, and headspace airflow system) in conjunction with one another to achieve predictive outcomes.

First claim

Opening claim text (preview).

What is claimed is: 1. A scalable bioreactor system for transitioning from testing to commercial production, comprising: a first bioreactor, comprising: a first bioprocessing container having a first end, a second end, a sidewall, and a first sparger affixed to the first end of the first bioprocessing container and having a first number of pores, each pore of the first number of pores having a first diameter; a first configurable mixing assembly suspended between the first and second ends of the first bioprocessing container; and a first impeller having a first diameter, the first impeller attached to the first configurable mixing assembly in a first position, wherein the first diameter and the first position are selected to achieve a set of operational parameters; a second bioreactor, comprising a second bioprocessing container having a first end, a second end, a sidewall, and a second sparger affixed to the first end of the second bioprocessing container and having a second number of pores, each pore of the second number of pores having a second diameter, wherein the second bioprocessing container is not the same volume as the first bioprocessing container; a second configurable mixing assembly suspended between the first and second ends of the second bioprocessing container; and a second impeller having a second diameter that is not the same as the first diameter, the second impeller attached to the second configurable mixing assembly in a second position, wherein the second diameter and the second position are selected to match the set of operational parameters and the operational parameters include power per volume and impeller tip speed. 2. The scalable bioreactor system of claim 1 , wherein the first number of pores is not the same as the second number of pores, the first diameter is not the same as the second diameter, and the number of pores and pores sizes are selected so that the first and second bioreactors attain the same kLa. 3. The scalable bioreactor system of claim 1 , wherein the first and second locations are selected to re-entrain gas bubbles rising out of the first and second spargers. 4. The scalable bioreactor system of claim 1 , wherein the first bioreactor includes a first headspace airflow device and the second bioreactor includes a second headspace airflow device and each of the first sparger and the second sparger operates to provide different rates of airflow across a headspace to match CO2 removal rates of the liquid phase to within five percent between the first and second bioreactors. 5. The scalable bioreactor system of claim 1 , wherein the second bioreactor includes a third impeller having a third diameter that is not the same as the first diameter, wherein the third impeller is attached to the second configurable mixing assembly and the third diameter and third attachment location are selected in combination with the second diameter and the second position to match the set of operational parameters. 6. The scalable bioreactor system of claim 1 , wherein the ratio of the first impeller diameter to the first bioprocessing container width is not the same as the ratio of the second impeller diameter to the second bioprocessing container width. 7. The scalable bioreactor system of claim 1 , wherein the set of operational parameters further includes bulk fluid flow and T95 mixing times. 8. The scalable bioreactor system of claim 1 , wherein the set of operational parameters is selected based on the optimal growth conditions for a cell. 9. The scalable bioreactor system of claim 8 , wherein the cell is eukaryotic and sensitive to a shear force that increases as the impeller tip speed increases. 10. The scalable bioreactor system of claim 1 , wherein the first bioprocessing container is a bench scale volume between 0.1 liters and 50 liters and the second bioprocessing container is a commercial volume between 50 liters and 10,000 liters. 11. The scalable bioreactor system of claim 1 , wherein the first and second bioprocessing containers are rectangular in shape and the first and second configurable mixing assemblies are offset from a center axis to increase bulk fluid flow. 12. The scalable bioreactor system of claim 1 , wherein the aspect ratio of the first and second bioprocessing containers is greater than 1.5. 13. The scalable bioreactor system of claim 1 , wherein the first bioprocessing container has an aspect ratio between 1.5 and 2 and the second bioprocessing container has an aspect ratio between 1.75 and 4.

Assignees

Inventors

Classifications

  • Automatic or computerized control (automatic analysis G01N35/00) · CPC title

  • Means for positioning or orientating the apparatus (C12M41/08 takes precedence) · CPC title

  • Stirrer or mobile mixing elements · CPC title

  • Mixing of ingredients for microbiology, enzymology, in vitro culture or genetic manipulation · CPC title

  • Bearings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12227732B2 cover?
The present set of embodiments relate to a bioproduction system, method, and apparatus for creating a scalable bioreactor system. Specifically, the present set of embodiments enable the determination of bioreaction performance characteristics of a commercial scale by matching operational parameters between a small test scale bioreaction to that of a commercial scale bioreaction. The system and …
Who is the assignee on this patent?
Life Technologies Corp
What technology area does this patent fall under?
Primary CPC classification C12M23/58. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).